newsfilter
← Latest News
GlobeNewswire·

Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate Update

SAN DIEGO, May 08, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a commercial-stage biopharmaceutical company primarily focused on developing and commercializing products in various